Organ-specific modifying effects of phenobarbital, saccharin and antioxidants on 2-stage chemical carcinogenesis.
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology; D002083:Butylated Hydroxyanisole / Q000494:pharmacology; D002084:Butylated Hydroxytoluene / Q000494:pharmacology; D002273:Carcinogens; D003110:Colonic Neoplasms / Q000139:chemically induced; D005015:Ethoxyquin / Q000494:pharmacology; D005982:Glutathione Transferase / Q000378:metabolism; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D008769:Methylnitronitrosoguanidine; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D010634:Phenobarbital / Q000494:pharmacology*; D011435:Propyl Gallate / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344; D012439:Saccharin / Q000494:pharmacology*; D013274:Stomach Neoplasms / Q000139:chemically induced; D013379:Substrate Specificity; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced
D000975:Antioxidants; D002273:Carcinogens; D008769:Methylnitronitrosoguanidine; D002084:Butylated Hydroxytoluene; D002083:Butylated Hydroxyanisole; D011435:Propyl Gallate; D005015:Ethoxyquin; D005982:Glutathione Transferase; D012439:Saccharin; D001205:Ascorbic Acid; D010634:Phenobarbital